Johnson & Johnson’s Janssen COVID-19 vaccine overview and safety

i

Up-to-date Information: Up-to-Date Info : To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Johnson & Johnson’s Janssen COVID-19 vaccine overview and safety

Supporting Files Public Domain

Oct. 29, 2021
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Oct. 29, 2021

NOTICE: FDA authorized the use of the Pfizer-BioNTech COVID-19 Vaccine for children ages 5 through 11 years. The Advisory Committee on Immunization Practices is meeting on Tuesday, November 2 to discuss a recommendation for this age group.
Subjects:

Child Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Viral Vaccines
Document Type:

Webpage
Name as Subject:

Johnson & Johnson’s Janssen COVID-19 vaccine
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:15531684a6f2e5ce0e884a7a8dc10ee60025c6cfb4ea32652d581cdb688df8eb
Download URL:

https://stacks.cdc.gov/view/cdc/111166/cdc_111166_DS1.pdf
File Type:

[PDF - 498.36 KB ]

Pfizer-BioNTech.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.